Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RLMD Stock Annual Cash Flow. Download in Excel

Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

0.36
 
USD
  
0.01
  
(2.89%)
Previous close: 0.3527  Open: 0.343  Bid: 0.365  Ask: 0.38
52 week range    
0.34   
   7.22
Mkt Cap: 11 M  Avg Vol (90 Days): 740,517
Peers   
CLCS / 
ETST / 
TARO / 
Last updated: Sunday 22nd December 2024

Stock Rankings

7
Technical
21
Quality
How are these ranks calculated?
Search for a stock

Financials

RLMD Cash Flow

Annual
Invalid dateAug-13Jun-16Jun-17Jun-18Jun-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current assets392394.059319.0
(Increase) Decrease in other current liabilities140914.0-716650.0708901.054634.0
(Increase) Decrease in payables424426.0-730153.0157392.0158920.08 M3 M421040.0-2 M
(Increase) Decrease in receivables-231942.0-655.0284299.0-104877.073091.079457.0-426055.0512432.0
CapitalExpenditureReported1800.0562256.049690.012391.0182 M
Cash at beginning of period8949.022 M9 M2 M2 M36 M2 M44 M5 M
Cash at end of period15290.09 M2 M2 M9 M36 M44 M5 M4 M
Cash flow-44765.0-13 M-6 M-6 M-10 M8 M-92 M-104 M-52 M
CashFlowFromContinuingInvestingActivities-1800.0-562256.0-49690.0-12391.0-34 M-54 M20 M50 M
ChangeInAccountPayable424426.0-730153.0157392.0158920.08 M3 M421040.0-2 M
ChangeInAccruedExpense152586.0-279612.0215632.01 M3 M-388560.03 M1 M
ChangeInInterestPayable152586.0-279612.0215632.01 M
ChangeInPayablesAndAccruedExpense577012.0-1 M373024.01 M11 M2 M4 M-274077.0
ChangeInPrepaidAssets1 M370333.042741.0270167.0-479327.0-10 M7 M3 M
ChangeInWorkingCapital2 M-964343.01 M2 M11 M-8 M11 M3 M
ChangesInAccountReceivables-512432.0
Depreciation54819.085271.02627.04870.03752.01258.0
Depreciation unreconciled250.054819.085271.01 M666038.03752.01258.0
DepreciationAndAmortization54819.085271.01 M666038.03752.01258.0
EarningsLossesFromEquityInvestments636012.0585522.0
FinancingCashFlow20000.0-263752.0-273670.07 M17 M28 M188 M45 M-98463.0
Free cash flow-13659.0-14 M-7 M-6 M-10 M-28 M-92 M-104 M-52 M
GainLossOnInvestmentSecurities-13 M-716650.0148 M585522.04 M
GainLossOnSaleOfPPE96403.0
InterestPaidSupplementalData3086.02651.02559.05933.02415.0
Issuance of capital stock20000.018 M20 M185 M43 M
Issuance of debt-263752.0-273670.07 M-285170.0-110247.0-50000.0
IssuanceOfCapitalStock20000.018 M20 M185 M43 M
IssuanceOfDebt-263752.0-273670.07 M-285170.0-110247.0-50000.0
Net cash from financing activities46341.0-263752.0-273670.07 M17 M28 M188 M45 M-98463.0
Net cash from investing activities-1800.0-562256.0-49690.0-12391.0-34 M-54 M20 M50 M
Net cash from operating activities-11859.0-13 M-6 M-6 M-10 M-28 M-92 M-104 M-52 M
Net change in cash & cash equivalents-224.0-14 M-7 M528431.07 M-34 M42 M-39 M-1 M
Net income from continuing operations-45015.0-3 M-6 M-9 M-17 M-59 M-126 M-157 M-99 M
NetCommonStockIssuance20000.018 M20 M185 M43 M
NetInvestmentPropertiesPurchaseAndSale-34 M-54 M20 M50 M
NetInvestmentPurchaseAndSale-34 M-54 M20 M50 M
NetIssuancePaymentsOfDebt-263752.0-273670.07 M-285170.0-110247.0-50000.0
NetLongTermDebtIssuance-273670.08500.0-285170.0
NetPPEPurchaseAndSale-1800.0-562256.0-49690.0-12391.0-182 M
Operating (gains) losses-13 M96403.04 M148 M636012.0585522.04 M
Other financing charges net26341.018 M28 M3 M323632.0
Other non-cash items1 M602855.0517999.05 M57 M41 M42 M40 M
ProceedsFromIssuanceOfWarrants8 M3 M1 M
ProceedsFromStockOptionExercised735514.0668431.0703720.0
Purchase of Float term investments-182 M-223 M-47 M-90 M
Purchase of property plant & equipment-1800.0-562256.0-49690.0-12391.0-182 M
PurchaseOfInvestment-182 M-223 M-47 M-90 M
PurchaseOfPPE-1800.0-562256.0-49690.0-12391.0-182 M
Repayment of debt-273670.08500.0-285170.0
RepaymentOfDebt-263752.0-273670.08500.0-285170.0-110247.0-50000.0
Revenue per share1 M661168.0
Sale of Float term investments148 M169 M
Sale of short term investments169 M67 M141 M
SaleOfInvestment148 M169 M67 M141 M
ShortTermDebtIssuance7 M
ShortTermDebtPayments-263752.0-273670.0-285170.0-110247.0-50000.0
StockBasedCompensation1 M704452.0517999.01 M21 M40 M44 M44 M
UnrealizedGainLossOnInvestmentSecurities-139267.04 M-4 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University